Optimization of Naltrexone Diclofenac Codrugs for Sustained Drug Delivery Across Microneedle-Treated Skin

Development of a Codrug Approach for Sustained Drug Delivery Across Microneedle-Treated Skin

(2013) Priyanka Ghosh et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Diclofenac delays micropore closure following microneedle treatment in human subjects

(2012) Nicole K. Brogden et al.   JOURNAL OF CONTROLLED RELEASE

Naltrexone Salt Selection for Enhanced Transdermal Permeation Through Microneedle-Treated Skin

(2012) Mikolaj Milewski et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin

(2010) Mikolaj Milewski et al.   JOURNAL OF CONTROLLED RELEASE

Vehicle Composition Influence on the Microneedle-Enhanced Transdermal Flux of Naltrexone Hydrochloride

(2010) Mikolaj Milewski et al.   PHARMACEUTICAL RESEARCH

Rapid Intradermal Delivery of Liquid Formulations Using a Hollow Microstructured Array

(2010) Scott A. Burton et al.   PHARMACEUTICAL RESEARCH

Formation and Closure of Microchannels in Skin Following Microporation

(2010) Haripriya Kalluri et al.   PHARMACEUTICAL RESEARCH

Scope and Limitations of The Co-Drug Approach to Topical Drug Delivery

(2008) W. Lau et al.   CURRENT PHARMACEUTICAL DESIGN

Human Skin Sermeation of 3-O-Alkyl Carbamate Prodrugs of Naltrexone

(2008) Haranath K. Vaddi et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Microneedles permit transdermal delivery of a skin-impermeant medication to humans

(2008) D. P. Wermeling et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA